Buzz e-sante
238.9K views | +4 today
Follow
Buzz e-sante
Le média du digital santé
Curated by Rémy TESTON
Your new post is loading...
Your new post is loading...
Scooped by Rémy TESTON
February 11, 2016 1:47 AM
Scoop.it!

La relation médecin-patient à l'ère des objets connectés

La relation médecin-patient à l'ère des objets connectés | Buzz e-sante | Scoop.it

Les avancées numériques et les transformations sociales résultantes ou motrices de ces innovations suscitent enthousiasme, débats et controverses, tant sur leur portée que sur les opportunités ou les...

No comment yet.
Rescooped by Rémy TESTON from eSalud Social Media
February 27, 2015 3:40 AM
Scoop.it!

Infographic: Today’s Digital Patient

Infographic: Today’s Digital Patient | Buzz e-sante | Scoop.it
Infographic illustrates today's digital patient and how they are willing to leverage health apps and wearable devices to improve their personal health

Via Ignacio Fernández Alberti
No comment yet.
Rescooped by Rémy TESTON from eHealth in Switzerland
May 31, 2014 2:36 PM
Scoop.it!

Tendances futures dans la santé

Les tendances futures au niveau technologique et numérique qui influenceront le domaine de la santé dans les années à venir.

Via ICT_Sierre
No comment yet.
Rescooped by Rémy TESTON from eHealth - Social Business in Health
January 13, 2014 8:40 AM
Scoop.it!

Definition of Health 2.0 and Medicine 2.0: A Systematic Review

Definition of Health 2.0 and Medicine 2.0: A Systematic Review | Buzz e-sante | Scoop.it
Definition of Health 2.0 and Medicine 2.0: A Systematic Review

ABSTRACT

Background: During the last decade, the Internet has become increasingly popular and is now an important part of our daily life. When new “Web 2.0” technologies are used in health care, the terms “Health 2.0" or "Medicine 2.0” may be used.
Objective: The objective was to identify unique definitions of Health 2.0/Medicine 2.0 and recurrent topics within the definitions.
Methods: A systematic literature review of electronic databases (PubMed, Scopus, CINAHL) and gray literature on the Internet using the search engines Google, Bing, and Yahoo was performed to find unique definitions of Health 2.0/Medicine 2.0. We assessed all literature, extracted unique definitions, and selected recurrent topics by using the constant comparison method.
Results: We found a total of 1937 articles, 533 in scientific databases and 1404 in the gray literature. We selected 46 unique definitions for further analysis and identified 7 main topics.
Conclusions: Health 2.0/Medicine 2.0 are still developing areas. Many articles concerning this subject were found, primarily on the Internet. However, there is still no general consensus regarding the definition of Health 2.0/Medicine 2.0. We hope that this study will contribute to building the concept of Health 2.0/Medicine 2.0 and facilitate discussion and further research.

(J Med Internet Res 2010;12(2):e18)

 

During the last decade, the Internet has become increasingly popular and now forms an important part of our daily life [1]. In the Netherlands, the Internet is even more popular than traditional media like television, radio, and newspapers [2]. Furthermore, the impact of the Internet and other technological developments on health care is expected to increase [3,4]. Patients are using search engines like Google and Bing to find health related information. In Google, five percent of all searches are health related [5]. Patients can express their feelings on weblogs and online forums [3], and patients and professionals can use the Internet to improve communication and the sharing of information on websites such as Curetogether [6] and the Dutch website, Artsennet [7] for medical professionals. The use of Internet or Web technology in health care is called eHealth [1,8].

In 2004 the term “Web 2.0” was introduced. O’Reilly defined Web 2.0 as “a set of economic, social, and technology trends that collectively form the basis for the next generation of the Internet, a more mature, distinctive medium characterized by user participation, openness, and network effects” [9]. Although there are different definitions, most have several aspects in common. Hansen defined Web 2.0 as “a term which refers to improved communication and collaboration between people via social networking” [10]. According to both definitions, the main difference between Web 1.0 (the first generation of the Internet) and Web 2.0 is interaction [11]. Web 1.0 was mostly unidirectional, whereas Web 2.0 allows the user to add information or content to the Web, thus creating interaction. This is why the amount of “user-generated content” has increased enormously [12]. Practical examples of user-generated content are online communities where users can participate and share content. Examples are YouTube, Flickr, Facebook, and microblogging such as Twitter. Twitter, for example, improves communication and the sharing of information among health care professionals [13]....


Via rob halkes
Scooped by Rémy TESTON
February 1, 2016 3:34 AM
Scoop.it!

INFOGRAPHIE : Internet, l’outil pour rechercher un professionnel de santé

INFOGRAPHIE : Internet, l’outil pour rechercher un professionnel de santé | Buzz e-sante | Scoop.it
No comment yet.
Rescooped by Rémy TESTON from The ehealth PULSE project
November 24, 2014 2:05 AM
Scoop.it!

Patient Engagement Strategy eBook | HL7 Standards

Patient Engagement Strategy eBook | HL7 Standards | Buzz e-sante | Scoop.it

Leonard Kish’s first eBook titled, “Patient Engagement is a Strategy, Not a Tool. How healthcare organizations can build true patient relationships that last a lifetime.”

 

This eBook explores the following patient engagement topics:

What Is Patient Engagement?The Quest for AttentionFrom Technology to MotivationThe Rise of Contextual MedicineAligning Goals with Effective MessagingAlignment Through Social StrategyEstablish a Patient Engagement Strategy 

Author Background

Leonard Kish is a long-time contributor to HL7Standards.com who writes about patient engagement topics as they relate to healthcare technology, the government’s Meaningful Use requirements, and how proven behavior economic models should be considered by healthcare organizations and companies focused on developing patient-facing technology

 

 download the free PDF

http://www.hl7standards.com/kish-ebook/

 

 


Via Ignacio Fernández Alberti
No comment yet.
Rescooped by Rémy TESTON from New pharma
May 16, 2014 4:20 AM
Scoop.it!

Samsung the pharmaceutical company, and the coming changes in rheumatoid and psoriatic arthritis

Samsung the pharmaceutical company, and the coming changes in rheumatoid and psoriatic arthritis | Buzz e-sante | Scoop.it

In case you haven’t heard: Samsung is now a pharmaceutical company, or at least on the point of becoming one. Subsequent to its having invested at least $2b in biopharmaceuticals, the South Korean giant will be bringing a biosimilar version of Amgen’s Enbrel to market in 2016.

That’s right.

In 2016, a company best known for its consumer electronics and heavily invested in mobile health is going to start producing pharmaceuticals, and will apparently begin by bringing a treatment to market which will presumably make it a dominant force overnight in the two disease areas in which Enbrel has indications, namely moderate to severe rheumatoid arthritis, and psoriatic arthritis.

The implications of this for legacy pharmaceutical companies are wide-reaching and significant. Let’s consider a few of them (I anticipate updating this post over the next few months):

- Samsung now has more touch points across the health ecosystem than any other pharmaceutical company. ...

- Samsung’s total focus on customer experience and design makes it a credible champion of the participatory patient’s interests. ...

- Hundreds of millions of people carry this pharmaceutical company’s brand with them day and night. ...

- Consumers will think of Samsung as a consumer electronics company that makes pharmaceuticals. ...

- Samsung will be the first consumer technology company to enter the pharmaceutical marketplace, but it will not be the last.

 

If this thought doesn’t focus legacy pharmaceutical companies into throwing everything they have into reforming themselves as social business, nothing will. The survival of even the largest companies is far from certain when giants such as Samsung have set their sights upon entering the industry.

 

Samsung doesn’t think like a pharmaceutical company.

 

Pharmaceutical companies better start thinking like Samsung.


Via rob halkes
rob halkes's curator insight, May 14, 2014 12:53 PM

Great blog by Andrew Spong, keen enough to see the great potential.. very much inspiring to all of pharma ;-) 

Must read, and still more: must think!